227 related articles for article (PubMed ID: 12869659)
1. Impact of drug transporter studies on drug discovery and development.
Mizuno N; Niwa T; Yotsumoto Y; Sugiyama Y
Pharmacol Rev; 2003 Sep; 55(3):425-61. PubMed ID: 12869659
[TBL] [Abstract][Full Text] [Related]
2. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
3. Transporters and drug therapy: implications for drug disposition and disease.
Ho RH; Kim RB
Clin Pharmacol Ther; 2005 Sep; 78(3):260-77. PubMed ID: 16153397
[TBL] [Abstract][Full Text] [Related]
4. Does inhibition of P-glycoprotein lead to drug-drug interactions?
Balayssac D; Authier N; Cayre A; Coudore F
Toxicol Lett; 2005 Apr; 156(3):319-29. PubMed ID: 15763631
[TBL] [Abstract][Full Text] [Related]
5. Altered functions and expressions of drug transporters in liver, kidney and intestine in disorders of local and remote organs: possible role of oxidative stress in the pathogenesis.
Ikemura K; Iwamoto T; Okuda M
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):907-20. PubMed ID: 19619071
[TBL] [Abstract][Full Text] [Related]
6. Importance of P-glycoprotein for drug-drug interactions.
Glaeser H
Handb Exp Pharmacol; 2011; (201):285-97. PubMed ID: 21103973
[TBL] [Abstract][Full Text] [Related]
7. Transporter-mediated uptake into cellular compartments.
Oswald S; Grube M; Siegmund W; Kroemer HK
Xenobiotica; 2007; 37(10-11):1171-95. PubMed ID: 17968742
[TBL] [Abstract][Full Text] [Related]
8. Transporters and their impact on drug disposition.
Beringer PM; Slaughter RL
Ann Pharmacother; 2005 Jun; 39(6):1097-108. PubMed ID: 15886292
[TBL] [Abstract][Full Text] [Related]
9. Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology.
Carson SW; Ousmanou AD; Hoyler SL
Psychopharmacol Bull; 2002; 36(1):67-81. PubMed ID: 12397848
[TBL] [Abstract][Full Text] [Related]
10. Role of transporters in drug interactions.
Han HK
Arch Pharm Res; 2011 Nov; 34(11):1865-77. PubMed ID: 22139686
[TBL] [Abstract][Full Text] [Related]
11. Drug transporters in the epileptic brain.
Löscher W
Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
Pardridge WM
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
[TBL] [Abstract][Full Text] [Related]
13. Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition.
Zhang T; Xiang CD; Gale D; Carreiro S; Wu EY; Zhang EY
Drug Metab Dispos; 2008 Jul; 36(7):1300-7. PubMed ID: 18411399
[TBL] [Abstract][Full Text] [Related]
14. Drug transporters: their role and importance in the selection and development of new drugs.
Mizuno N; Sugiyama Y
Drug Metab Pharmacokinet; 2002; 17(2):93-108. PubMed ID: 15618657
[TBL] [Abstract][Full Text] [Related]
15. Drug transporters as targets for cancer chemotherapy.
Nakanishi T
Cancer Genomics Proteomics; 2007; 4(3):241-54. PubMed ID: 17878527
[TBL] [Abstract][Full Text] [Related]
16. Spatial expression and functionality of drug transporters in the intact lung: objectives for further research.
Gumbleton M; Al-Jayyoussi G; Crandon-Lewis A; Francombe D; Kreitmeyr K; Morris CJ; Smith MW
Adv Drug Deliv Rev; 2011; 63(1-2):110-8. PubMed ID: 20868712
[TBL] [Abstract][Full Text] [Related]
17. The genetic polymorphism of drug transporters: functional analysis approaches.
Ishikawa T; Tsuji A; Inui K; Sai Y; Anzai N; Wada M; Endou H; Sumino Y
Pharmacogenomics; 2004 Jan; 5(1):67-99. PubMed ID: 14683421
[TBL] [Abstract][Full Text] [Related]
18. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
Feng B; LaPerle JL; Chang G; Varma MV
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
[TBL] [Abstract][Full Text] [Related]
19. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
Sun J; He ZG; Cheng G; Wang SJ; Hao XH; Zou MJ
Med Sci Monit; 2004 Jan; 10(1):RA5-14. PubMed ID: 14704647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
